2025 Annual Meeting | C150 - Child Neurology: Neuromuscular and Movement Disorders

Date Tuesday 04/08/25

Time 01:00 PM - 03:00 PM PDT Add To Calendar

Location San Diego Convention Center | 29A

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Clara Chow Haws, MD

Topic(s) Child Neurology and Developmental Neurology, Movement Disorders, Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives Participants should become familiar with recent updates in Duchenne muscular dystrophy, spinal muscular atrophy, and other selected topics within pediatric neuromuscular disease, including pediatric myasthenia gravis, pediatric Guillain-Barre syndrome, and hereditary neuropathies.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:05 PM PDT	Introduction	Introduction of Speakers Clara Chow Haws, MD
01:05 PM - 01:40 PM PDT	Speaker	Updates in Duchenne Muscular Dystrophy Seth J. Perlman, MD
01:40 PM - 02:15 PM PDT	Speaker	Updates in Spinal Muscular Atrophy Stephanie Manberg, DO
02:15 PM - 02:50 PM PDT	Speaker	Other Updates in Pediatric Neuromuscular Disease Clara Chow Haws, MD
02:50 PM - 03:00 PM PDT	Speaker	Questions and Answers Clara Chow Haws, MD, Stephanie Manberg, DO, Seth J. Perlman, MD

Faculty Disclosures
Clara Chow Haws, MD	Dr. Chow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Chow has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta.
Stephanie Manberg, DO	The institution of Dr. Manberg has received research support from AMO.
Seth J. Perlman, MD	Dr. Perlman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Perlman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid Biosciences. Dr. Perlman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. The institution of Dr. Perlman has received research support from Scholar Rock. The institution of Dr. Perlman has received research support from Pfizer. The institution of Dr. Perlman has received research support from Sarepta. The institution of Dr. Perlman has received research support from ReveraGen. The institution of Dr. Perlman has received research support from FibroGen. The institution of Dr. Perlman has received research support from PTC Therapeutics. The institution of Dr. Perlman has received research support from CSL Behring. Dr. Perlman has a non-compensated relationship as a Registry Committee Member with Cure SMA that is relevant to AAN interests or activities. Dr. Perlman has a non-compensated relationship as a Assessment Program Pilot Committee Member with American Board of Psychiatry & Neurology that is relevant to AAN interests or activities.

��ɫ��

��ɫ��